Development and application of a UPLC-MS/MS method for P-glycoprotein quantification in human tumor cells

被引:8
|
作者
Qiu, Zhaohui [1 ]
Peng, Jie [1 ]
Mou, Lingli [2 ]
Li, Xiao [3 ]
Meng, Fanqi [1 ]
Yu, Peng [1 ]
机构
[1] Cent S Univ, Sch Xiangya Pharmaceut Sci, 172 Tong Zi Po Rd, Changsha 410013, Hunan, Peoples R China
[2] Hunan Normal Univ, Med Coll, 371 Tong Zi Po Rd, Changsha 410006, Hunan, Peoples R China
[3] Changsha Duxact Biotech Co Ltd, C10 Bldg,Lugu S&T Pk,28 Lutian Rd, Changsha 411000, Hunan, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2018年 / 1084卷
关键词
UPLC-MS/MS; P-gp quantification; Human tumor cells; Linear regression; TANDEM MASS-SPECTROMETRY; MEDIATED MULTIDRUG-RESISTANCE; TARGETED PROTEOMICS; DRUG TRANSPORTERS; EXPRESSION; QUANTITATION; PROTEINS; PROLIFERATION;
D O I
10.1016/j.jchromb.2018.03.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multidrug resistance (MDR) of tumors occurs when tumor cells exhibit reduced sensitivity to a large number of unrelated drugs. The molecular mechanism of MDR commonly involves overexpression of the plasma membrane drug efflux pump P-glycoprotein (P-gp). Overexpression of P-gp may be induced by the selection and/or adaptation of cells during exposure to chemotherapeutic drugs, referred to as acquired P-gp-mediated MDR. This study aimed to establish a P-gp quantification method by Ultra Performance Liquid Chromatography and Tandem Mass Spectrometry (UPLC-MS/MS) to better understand the regulation of P-gp expression and its relationship with the level of drug resistance. Absolute P-gp expression was determined in the human tumor cells MCF-7, HepG-2, and SMMC-7721 and their corresponding drug-resistant subclones MCF-7/ADMs, MCF-7MXs, MCF-7/MTXs, HepG-2/ADMs, HepG-2/MXs, HepG-2/MIXs, SMMC-7721/ADMs, SMMC-7721/MXs and SMMC-7721/MTXs. A unique 10-mer Cryptic peptide (IATEAIENFR) of P-gp was synthesized for developing the quantitative UPLC-MS/MS method with the stable isotope labeled signature peptide IATEAI (C-13(6), N-15(1)) ENFR as the internal standard (IS). The detection signal was linear in the range of 0.1-100 ng mL(-1). Quality control (QC) data showed that the within-run and between-run precision (%RSD) and accuracy (%RE) conformed to acceptable criteria of +/- 15% for the calibration standards and QCs (+/- 20% at the LLOQ). The UPLC-MS/MS method was first applied to quantify P-gp in HepG-2 and SMMC-7721 cells and their drug-resistant subclones. The results confirmed that P-gp expression in most drug-resistant subclones increase significantly compared to parental tumor cells but varied among different types of drugs or tumor cells. This outcome was then compared with published reports and discrepancy was observed in HepG2 cell lines mainly due to different sample types and samples sources. Additionally, P-gp mRNA results ascertained that overexpression of P-gp in subclones was not only regulated by MDR1. The linear correlation between RI and logarithm-transformed P-gp expression was moderate or high and statistically significantly different in subclones, except for SMMC-7721/ADMs. The present study is the first to demonstrate the quantitative relationship between RI and P-gp expression by linear regression modeling and expanded the number of efflux transporters related to MDR quantifiable by LC-MS/MS to better understand the biological significance of effluent transporter expression.
引用
收藏
页码:14 / 22
页数:9
相关论文
共 50 条
  • [1] Development, validation, and application of a simple UPLC-MS/MS method for simultaneous quantification of five traditional antipsychotics in human plasma
    Fan, Liju
    An, Jing
    Cui, Yanjun
    Dong, Zhanjun
    BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (09)
  • [2] Development and validation of UPLC-MS/MS method for determination of domperidone in human plasma and its pharmacokinetic application
    Wang, Xintao
    Qin, Feng
    Jing, Lijuan
    Zhu, Qiang
    Li, Famei
    Xiong, Zhili
    BIOMEDICAL CHROMATOGRAPHY, 2013, 27 (03) : 371 - 376
  • [3] Development and validation of a rapid, simple, and reliable UPLC-MS/MS method for the quantification of vancomycin in human plasma
    Vinh, Tho Do Chau Minh
    Thanh, Sil Nguyen
    Bich, Tram To
    Diem, Tien Le Thi
    Anh, Thi Huynh Huynh
    Do, Tuyen Ngoc
    PHARMACIA, 2024, 71
  • [4] Development and validation of a UPLC-MS/MS method for quantification of doxofylline and its metabolites in human plasma
    Fang, Li-Na
    Mao, Ming-Qing
    Zhao, Xiao-Hua
    Yang, Ling
    Jia, Hui
    Xia, Shu-Yue
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2019, 174 : 220 - 225
  • [5] Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence study
    Du, Ping
    Li, Pengfei
    Zhao, Rui
    Liu, Hongchuan
    Liu, Lihong
    BIOANALYSIS, 2019, 11 (13) : 1291 - 1302
  • [6] Development and Validation of an UPLC-MS/MS Method for the Determination of Enalapril in Human Plasma
    Zhao, Jian-long
    Zheng, Xiao-kang
    Yin, Shi
    Wei, Jia-nan
    Yi, Xiao-wen
    Qiu, Xiang-jun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2016, 35 (05): : 945 - 949
  • [7] Development and Validation of UPLC-MS/MS Method for the Determination of Andrographolide in Human Plasma
    Yuan, Hongchang
    Feng, Jianfang
    Zhang, Dongtao
    Zhang, Jie
    Wang, Yajun
    Qiu, Xiangjun
    LATIN AMERICAN JOURNAL OF PHARMACY, 2015, 34 (06): : 1205 - 1210
  • [8] Highly sensitive UPLC-MS/MS method for the quantification of paromomycin in human plasma
    Roseboom, Ignace C.
    Thijssen, Bas
    Rosing, Hilde
    Mbui, Jane
    Beijnen, Jos H.
    Dorlo, Thomas P. C.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 185
  • [9] Development and validation of a UPLC-MS/MS assay for the quantification of simotinib in human plasma
    Li, Ning
    Han, Xiaohong
    Du, Ping
    Song, Yuanyuan
    Hu, Xingsheng
    Yang, Sheng
    Shi, Yuankai
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2014, 406 (06) : 1799 - 1805
  • [10] Simple and rapid UPLC-MS/MS method for quantification of entecavir in human plasma: Application to a bioequivalence study
    Hou, Zhen-yan
    Yan, Miao
    Cai, Hua-lin
    Deng, Yang
    Wu, Hui-hui
    Tang, Zhi
    Hu, Xiao-yang
    Yang, Xi-ding
    Zhang, Bi-kui
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (04) : 197 - 204